Importance of both the coding and the segment-specific noncoding regions of the influenza A virus NS segment for its efficient incorporation into virions.
The genome of influenza A virus consists of eight single-strand negative-sense RNA segments, each comprised of a coding region and a noncoding region. The noncoding region of the NS segment is thought to provide the signal for packaging; however, we recently showed that the coding regions located at both ends of the hemagglutinin and neuraminidase segments were important for their incorporation into virions. In an effort to improve our understanding of the mechanism of influenza virus genome packaging, we sought to identify the regions of NS viral RNA (vRNA) that are required for its efficient incorporation into virions. Deletion analysis showed that the first 30 nucleotides of the 3' coding region are critical for efficient NS vRNA incorporation and that deletion of the 3' segment-specific noncoding region drastically reduces NS vRNA incorporation into virions. Furthermore, silent mutations in the first 30 nucleotides of the 3' NS coding region reduced the incorporation efficiency of the NS segment and affected virus replication. These results suggested that segment-specific noncoding regions together with adjacent coding regions (especially at the 3' end) form a structure that is required for efficient influenza A virus vRNA packaging.
Fujii
Ken
K
Institute of Medical Science, University of Tokyo, Shirokanedai, Minato-ku, Tokyo 108-8639, Japan. kawaoka@ims.u-tokyo.ac.jp.
Fujii
Yutaka
Y
Noda
Takeshi
T
Muramoto
Yukiko
Y
Watanabe
Tokiko
T
Takada
Ayato
A
Goto
Hideo
H
Horimoto
Taisuke
T
Kawaoka
Yoshihiro
Y
D001483:Base Sequence; D017930:Genes, Reporter; D049452:Green Fluorescent Proteins / Q000235:genetics / Q000378:metabolism; D006801:Humans; D009980:Influenza A virus / Q000254:growth & development / Q000502:physiology*; D008969:Molecular Sequence Data; D016366:Open Reading Frames; D017354:Point Mutation; D022661:RNA, Untranslated / Q000235:genetics / Q000502:physiology; D012367:RNA, Viral / Q000235:genetics* / Q000378:metabolism*; D017384:Sequence Deletion; D017361:Viral Nonstructural Proteins / Q000235:genetics* / Q000502:physiology*; D019065:Virus Assembly / Q000502:physiology*
C108309:NS protein, influenza virus; D022661:RNA, Untranslated; D012367:RNA, Viral; D017361:Viral Nonstructural Proteins; D049452:Green Fluorescent Proteins
EMBO J. 2000 Dec 15;19(24):6751-8
11118210
Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9345-50
10430945
Virology. 2001 Apr 10;282(2):215-20
11289803
Virus Res. 2001 Sep;77(1):31-42
11451485
Nat Med. 2001 Dec;7(12):1306-12
11726970
J Virol. 2002 Jan;76(2):767-73
11752166
J Virol. 2002 Jul;76(14):7133-9
12072513
Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10736-41
12149435
Nat Med. 2002 Sep;8(9):950-4
12195436
Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):2002-7
12574509
J Virol. 2003 Oct;77(19):10575-83
12970442
Proc Natl Acad Sci U S A. 1976 Sep;73(9):3045-9
1067600
Nucleic Acids Res. 1979 Aug 24;6(12):3745-57
493121
Virology. 1981 Aug;113(1):397-402
6927848
Virology. 1985 Apr 15;142(1):68-77
2997982
Genetics. 1988 Nov;120(3):621-3
2852134
Virology. 1989 Jul;171(1):1-9
2525836
J Virol. 1989 Dec;63(12):5142-52
2585601
Cell. 1989 Dec 22;59(6):1107-13
2598262
J Virol. 1991 Jun;65(6):2861-7
2033659
Cell. 1991 Oct 4;67(1):117-30
1913813
Gene. 1991 Dec 15;108(2):193-9
1660837
J Virol. 1994 Feb;68(2):1245-9
7507179
J Virol. 1997 Sep;71(9):6706-13
9261394
EMBO J. 1998 Jan 2;17(1):288-96
9427762
Virus Res. 1998 Jun;55(2):143-56
9725667
J Virol. 2001 Jan;75(1):408-19
11119609